מזומני החברה admabiologics.com (ADMA)

ADMA Biologics specializes in developing plasma-derived therapies, leveraging the efficiency of its own raw material collection network. Operating cash flow demonstrates liquidity dynamics, where the value of 0.13 captures the metric level. The company is developing a closed-loop production cycle with proprietary fractionation, which ensures patient retention. However, reliance on collection center operations and market competition create certain operational challenges.
פילוחי נתונים אנליטיים מרוכזים עבור ADMA Biologics Inc (ADMA)

This indicator measures the actual volume of liquid resources, allowing the investor to assess the asset's financial stability and the risk of operational capital depletion during periods of market volatility. Driven by an extreme shortage of plasma-derived medicines and high margins, the cash trajectory of ADMA Biologics confirms the company's ability to accumulate a significant cash reserve through its dominant pricing power.